Skip to content
The Policy VaultThe Policy Vault

Nexavar (sorafenib tablets)Cigna

Bone Cancer

Initial criteria

  • Patient age ≥ 18 years
  • Patient has recurrent chordoma OR has osteosarcoma and has tried one systemic chemotherapy regimen (examples include cisplatin, doxorubicin, methotrexate, or ifosfamide)

Approval duration

1 year